curios... I just checked over a few ASX listed diagnostic imaging stocks.
SHL, CAJ, HLS, PME, M7T & IDX...
all of these have been on a downward trend since Jan22...
exception to these is RHC - but it is also more diversified with hospitals and pharmaceuticals also under the same banner.
I wonder if there is some form of headwind present in the sector which is impacting margins? Or is this all COVID related reductions? (AFAIK - covid actually saw a boost in government spending (Medicare) in this area = a reduction in future earnings as we find out what "new normal" is).
It is a highly fragmented market - which should provide scale benefits
Ann: Infratil Infrastructure Bond Exchange Offer Closes, page-4
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$10.57 |
Change
0.390(3.83%) |
Mkt cap ! $10.35B | |||
| Open | High | Low | Value | Volume |
| $10.24 | $10.65 | $10.22 | $1.876M | 178.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 2673 | $10.55 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $10.57 | 5322 | 1 |
View Market Depth
| Last trade - 16.12pm 25/07/2025 (20 minute delay) ? |
| IFT (ASX) Chart |